S Christgau

Summary

Publications

  1. ncbi request reprint Collagen type II C-telopeptide fragments as an index of cartilage degradation
    S Christgau
    Osteometer BioTech A S, Herlev, Denmark
    Bone 29:209-15. 2001
  2. ncbi request reprint Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides
    S Christgau
    Osteometer BioTech A S, Osteopark, Herlev Hovedgade, Denmark
    Clin Chem 44:2290-300. 1998
  3. ncbi request reprint Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy
    S Christgau
    Osteometer BioTech A S, Osteopark, Herlev, Denmark
    Bone 26:505-11. 2000
  4. ncbi request reprint Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting
    P Qvist
    Osteometer BioTech A S, Herlev, Denmark
    Bone 31:57-61. 2002
  5. ncbi request reprint Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphate
    S Christgau
    Nordic Bioscience A S, Herlev, Denmark
    Clin Exp Rheumatol 22:36-42. 2004
  6. pmc Effect of bisphosphonates on cartilage turnover assessed with a newly developed assay for collagen type II degradation products
    H J Lehmann
    Centre for Clinical and Basic Research, Ballerup, Denmark Osteometer Biotech A S, Herlev, Denmark
    Ann Rheum Dis 61:530-3. 2002

Detail Information

Publications6

  1. ncbi request reprint Collagen type II C-telopeptide fragments as an index of cartilage degradation
    S Christgau
    Osteometer BioTech A S, Herlev, Denmark
    Bone 29:209-15. 2001
    ..This suggests that the assay may have clinical value in assisting in the diagnosis of joint diseases and in monitoring progression and therapy in RA and OA...
  2. ncbi request reprint Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides
    S Christgau
    Osteometer BioTech A S, Osteopark, Herlev Hovedgade, Denmark
    Clin Chem 44:2290-300. 1998
    ..Further studies are needed to optimize its use in this and other clinical applications...
  3. ncbi request reprint Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy
    S Christgau
    Osteometer BioTech A S, Osteopark, Herlev, Denmark
    Bone 26:505-11. 2000
    ..In conclusion, the serum CTx showed high specificity and sensitivity for monitoring individual responses to antiresorptive therapy. More than 92% of the treated women showed significant responses in serum CTx measurements after 6 months...
  4. ncbi request reprint Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting
    P Qvist
    Osteometer BioTech A S, Herlev, Denmark
    Bone 31:57-61. 2002
    ..From a practical point of view the results of this study demonstrate that samples for sCTx should be taken in the fasting state...
  5. ncbi request reprint Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphate
    S Christgau
    Nordic Bioscience A S, Herlev, Denmark
    Clin Exp Rheumatol 22:36-42. 2004
    ..We investigated whether early response in a newly developed biochemical marker of collagen type II degradation (CTX-II, CartiLaps ELISA) could reflect the long-term preservation of hyaline cartilage...
  6. pmc Effect of bisphosphonates on cartilage turnover assessed with a newly developed assay for collagen type II degradation products
    H J Lehmann
    Centre for Clinical and Basic Research, Ballerup, Denmark Osteometer Biotech A S, Herlev, Denmark
    Ann Rheum Dis 61:530-3. 2002
    ..Animal studies of arthritis have suggested that bisphosphonates may have chondroprotective abilities...